Common Stock, Shares, Outstanding of CNBX Pharmaceuticals Inc. from 31 Aug 2013 to 30 Nov 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CNBX Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Aug 2013 to 30 Nov 2025.
  • CNBX Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Nov 2025 was 753,196,666, a 2321% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

CNBX Pharmaceuticals Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 753,196,666 +722,085,314 +2321% 30 Nov 2025 10-Q 14 Jan 2026 2026 Q1
Q3 2025 553,962,206 +522,850,854 +1681% 31 Aug 2025 10-Q 14 Jan 2026 2026 Q1
Q2 2025 92,511,352 +89,400,000 +2873% 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 33,861,352 +30,750,000 +988% 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 31,111,352 +2,800,000 +9.9% 30 Nov 2024 10-Q 13 Jan 2025 2025 Q1
Q3 2024 31,111,352 +8,500,000 +38% 31 Aug 2024 10-K 01 Dec 2025 2025 FY
Q2 2024 3,111,352 -12,922,380 -81% 31 May 2024 10-Q 15 Jul 2024 2025 Q3
Q1 2024 3,111,352 +901,967 +41% 29 Feb 2024 10-Q 16 Apr 2024 2024 Q2
Q4 2023 28,311,352 +27,053,425 +2151% 30 Nov 2023 10-Q 12 Jan 2024 2024 Q1
Q3 2023 22,611,352 +21,372,693 +1725% 31 Aug 2023 10-K 29 Nov 2024 2024 FY
Q2 2023 16,033,732 +14,794,906 +1194% 31 May 2023 10-Q 14 Jul 2023 2023 Q3
Q1 2023 2,209,385 -147,227,296 -99% 28 Feb 2023 10-Q 14 Apr 2023 2023 Q2
Q4 2022 1,257,927 -147,403,320 -99% 30 Nov 2022 10-Q 13 Jan 2023 2023 Q1
Q3 2022 1,238,659 -147,422,588 -99% 31 Aug 2022 10-K 30 Nov 2023 2023 FY
Q2 2022 1,238,826 -141,337,421 -99% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 149,436,681 +14,199,097 +10% 28 Feb 2022 10-Q 12 Apr 2022 2022 Q2
Q4 2021 148,661,247 +13,423,663 +9.9% 30 Nov 2021 10-Q 13 Jan 2022 2022 Q1
Q3 2021 148,661,247 +13,580,806 +10% 31 Aug 2021 10-K 30 Nov 2022 2022 FY
Q2 2021 142,576,247 +7,495,806 +5.5% 31 May 2021 10-Q 14 Jul 2021 2021 Q3
Q1 2021 135,237,584 +202,143 +0.15% 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 135,237,584 +818,809 +0.61% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 135,080,441 +581,666 +0.43% 31 Aug 2020 10-K 29 Nov 2021 2021 FY
Q2 2020 135,080,441 +621,666 +0.46% 31 May 2020 10-Q 14 Jul 2020 2020 Q3
Q1 2020 135,035,441 +2,840,610 +2.1% 29 Feb 2020 10-Q 13 Apr 2020 2020 Q2
Q4 2019 134,418,775 +2,585,610 +2% 30 Nov 2019 10-Q 14 Jan 2020 2020 Q1
Q3 2019 134,498,775 +12,923,387 +11% 31 Aug 2019 10-K 04 Nov 2020 2020 FY
Q2 2019 134,458,775 +13,636,993 +11% 31 May 2019 10-Q 15 Jul 2019 2019 Q3
Q1 2019 132,194,831 +11,709,159 +9.7% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 131,833,165 +12,268,325 +10% 30 Nov 2018 10-Q 17 Jan 2019 2019 Q1
Q3 2018 121,575,388 +2,030,548 +1.7% 31 Aug 2018 10-K 29 Nov 2019 2019 FY
Q2 2018 120,821,782 +2,499,161 +2.1% 31 May 2018 10-Q 16 Jul 2018 2018 Q3
Q1 2018 120,485,672 +5,809,439 +5.1% 28 Feb 2018 10-Q 05 Apr 2018 2018 Q2
Q4 2017 119,564,840 +5,487,606 +4.8% 30 Nov 2017 10-Q 16 Jan 2018 2018 Q1
Q3 2017 119,544,840 +12,322,937 +11% 31 Aug 2017 10-K 29 Nov 2018 2017 FY
Q2 2017 118,322,621 +11,295,956 +11% 31 May 2017 10-Q 17 Jul 2017 2017 Q3
Q1 2017 114,676,233 +12,022,899 +12% 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 114,077,234 +11,923,901 +12% 30 Nov 2016 10-Q 17 Jan 2017 2017 Q1
Q3 2016 107,221,903 +5,718,570 +5.6% 31 Aug 2016 10-K 08 Dec 2017 2017 FY
Q2 2016 107,026,665 +6,303,332 +6.3% 31 May 2016 10-Q 13 Jul 2016 2016 Q3
Q1 2016 102,653,334 +2,020,001 +2% 29 Feb 2016 10-Q 18 Apr 2016 2016 Q2
Q4 2015 102,153,333 +1,520,000 +1.5% 30 Nov 2015 10-Q/A 08 Apr 2016 2016 Q1
Q3 2015 101,503,333 +1,253,333 +1.2% 31 Aug 2015 10-K 13 Dec 2016 2016 FY
Q2 2015 100,723,333 +18,962,927 +23% 31 May 2015 10-Q/A 17 Nov 2015 2015 Q3
Q1 2015 100,633,333 +79,753,130 +382% 28 Feb 2015 10-Q/A 17 Nov 2015 2015 Q2
Q4 2014 100,633,333 +79,953,130 +387% 30 Nov 2014 10-Q/A 17 Nov 2015 2015 Q1
Q3 2014 100,250,000 +98,889,594 +7269% 31 Aug 2014 10-K 07 Jan 2016 2015 FY
Q2 2014 81,760,406 31 May 2014 10-Q 15 Jul 2014 2014 Q3
Q1 2014 20,880,203 28 Feb 2014 10-Q 01 Apr 2014 2014 Q2
Q4 2013 20,680,203 30 Nov 2013 10-Q 14 Jan 2014 2014 Q1
Q3 2013 1,360,406 31 Aug 2013 10-K/A 23 Oct 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.